Clara Liao

This study shows psilocybin selectively affects GABAergic interneurons in the mouse medial frontal cortex, reducing somatostatin-expressing and increasing parvalbumin-expressing neuron activity.

This study shows psilocybin prolongs neurovascular coupling in mouse visual cortex, affecting blood flow without altering neural responses, and suggests implications for interpreting human neuroimaging data.

The paper classifies psychedelics and psychoactive drugs using brain-wide imaging of c-Fos expression and machine learning, achieving above-chance accuracy in drug identification.

This study uses single-nucleus RNA sequencing to show psilocybin and ketamine induce cell type-specific and time-dependent gene expression changes in mouse medial frontal cortex neurons.

This study identifies specific pyramidal cell types and 5-HT2A receptors in the medial frontal cortex as essential for psilocybin's long-term therapeutic effects.

This study shows that reducing Nemo-like kinase enhances lysosome biogenesis and improves TDP-43 clearance, alleviating neurodegeneration in mouse models.

This study investigates the behavioral and neural effects of 5-MeO-DMT in mice, showing dose-dependent changes in behavior and long-term dendritic spine density increases without affecting spine size.

This study shows psilocybin rapidly and persistently increases dendritic spine size and density in mouse frontal cortex, with lasting behavioral and neurophysiological effects.

The paper investigates antioxidant gene expression in the vocal hindbrain of midshipman fish, finding no significant differences in sod1 and sod2 transcripts between humming and non-humming males or male morphs.